Antimicrobial resistance in Enterobacteriaceae in Brooklyn, NY: Epidemiology and relation to antibiotic usage patterns

Journal of Antimicrobial Chemotherapy

Volumn 45, Issue 6, 2000, Pages 895-898

  Saurina, Guillermo ^a   Quale, John M ^a   Manikal, Vivek M ^a   Oydna, Elise ^b   Landman, David ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAMASE; CARBAPENEM DERIVATIVE; CEFEPIME; CEFOTETAN; CEFPODOXIME; CEFTAZIDIME; CEPHALOSPORIN; CIPROFLOXACIN; CLAVULANIC ACID; GATIFLOXACIN; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN; SULTAMICILLIN; TAZOBACTAM; TROVAFLOXACIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; DRUG USE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; GRAM NEGATIVE INFECTION; HUMAN; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; PROTEUS MIRABILIS; PULSED FIELD GEL ELECTROPHORESIS; UNITED STATES;

EID: 0034077489     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/45.6.895     Document Type: Article

References (8)

1. Landman, D., Chockalingam, M. & Quale, J. M. (1999). Reduction in the incidence of methicillin-resistant Staphylococcus aureus and ceftazidime-resistant Klebsiella pneumoniae following changes in a hospital antibiotic formulary. Clinical Infectious Diseases 28, 1062-6.
2. Rahal, J. J., Urban, C., Horn, D., Freeman, K., Segal-Maurer, S., Maurer, J. et al. (1998). Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. Journal of the American Medical Association 280, 1233-7.
3. National Committee for Clinical Laboratory Standards. (1998). Performance Standards for Antimicrobial Susceptibility Testing - Eighth Informational Supplement. M100-S8. NCCLS, Villanova, PA.
4. Barrett, T. J., Lior, H., Green, J. H., Khakhria, R., Wells, J. G., Bell, B. P. et al. (1994). Laboratory investigation of a multistate food-borne outbreak of Escherichia coliO157:H7 by using pulsed-field gel electrophoresis and phage typing. Journal of Clinical Microbiology 32, 3013-7.
5. National Nosocomial Infections Surveillance. (1998). System Report, data summary from October 1986-April 1998, issued June 1998. American Journal of Infection Control 26, 522-33.
6. Jones, R. N., Pfaller, M. A., Doern, G. V., Erwin, M. E. & Hollis, R. J. (1998). Antimicrobial activity and spectrum investigation of eight broad-spectrum β-lactam drugs: a 1997 surveillance trial in 102 medical centers in the United States. Diagnostic Microbiology and Infectious Disease 30, 215-28.
7. Bradford, P. A., Urban, C., Mariano, N., Projan, S. J., Rahal, J. J. & Bush, K. (1997). Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the loss of an outer membrane protein. Antimicrobial Agents and Chemotherapy 41, 563-9.
8. Monnet, D. L., Biddle, J. W., Edwards, J. R., Culver, D. H., Tolson, J. H., Martone, W. J. et al. (1997). Evidence of interhospital transmission of extended-spectrum β-lactam-resistant Klebsiella pneumoniae in the United States, 1986 to 1993. Infection Control and Hospital Epidemiology 18, 492-8.